/

Bortezomib

CAS 179324-69-7

Overview

Boltezomib is an anti-cancer drug used to treat multiple myeloma and mantle cell lymphoma. This includes those who have not been treated before and multiple myeloma. It is commonly used in combination with other drugs. It is given by injection

Anant Labs manufacture and furnish high quality Bortezomib impurities for global markets. Our Bortezomib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Bortezomib

Bortezomib

Cat. No.: ANT-BTZ-00
CAS: 179324-69-7
Mol. Formula: C₁₉H₂₅BN₄O₄
Mol. Weight: 384.24

Impurities (6)

Chemical structure of Bortezomib Impurity 1

Bortezomib Impurity 1

Cat. No.: ANT-BTZ-01
CAS: 114457-94-2
Mol. Formula: C₁₄H₁₃N₃O₃
Mol. Weight: 271.28

Chemical structure of Bortezomib Impurity 2

Bortezomib Impurity 2

Cat. No.: ANT-BTZ-02
CAS: 289472-78-2
Mol. Formula: C₁₉H₂₄N₄O₃
Mol. Weight: 356.43

Chemical structure of Bortezomib Impurity 26

Bortezomib Impurity 26

Cat. No.: ANT-BTZ-005
CAS: 78-77-3
Mol. Formula: C₄H₉Br
Mol. Weight: 137

Chemical structure of Bortezomib Impurity 3

Bortezomib Impurity 3

Cat. No.: ANT-BTZ-03
CAS: 289472-80-6
Mol. Formula: C₁₄H₁₄N₄O₂
Mol. Weight: 270.29

Chemical structure of Bortezomib Pinanediol Ester

Bortezomib Pinanediol Ester

Cat. No.: ANT-BTZ-006
CAS: 205393-22-2
Mol. Formula: C₂₉H₃₉BN₄O₄
Mol. Weight: 518.46

Chemical structure of Bortezomib USP Impurity G

Bortezomib USP Impurity G

Cat. No.: ANT-BTZ-04
CAS: 1132709-14-8
Mol. Formula: C₁₉H₂₅BN₄O₄
Mol. Weight: 384.24